The Study of Hemp Oil CBD for Evaluation of Efficacy and Safety in Treatment of Pain, Anxiety and Insomnia Management
Unknown statusPhase 1NCT04729244
View the official record on ClinicalTrials.gov Recruiting status changes often. Contact the study team listed on ClinicalTrials.gov, and talk to your doctor before joining a study.
This study has no listed site in Canada in this snapshot. It is included as part of the worldwide chronic pain corpus.
Brief summary (from the registry)
The investigators are looking to conduct a study looking at the effects of cannabidiol (CBD) from Hemp Oil in patients with Chronic pain, anxiety and insomnia. It is believed that CBD will improve pain anxiety and sleep quality and reduce opioid use. The study will last a total of 4 weeks and involve onsite visits in addition to weekly pain assessments.
Study details
- Official title
- Critical Review of Efficacy of Hemp Oil (CBD) Tincture and Cream for Treatment of Pain, Anxiety, Insomnia and Reduction of Opioid Use
- Conditions
- Interventions
- Drug: CBD
- Sponsor
- Advanced Pain and Rehab Specialists
- Collaborators
- Hemp synergistics
- Start date
- 2021-09-01
- Primary completion
- 2021-11-01
- Sex
- All
- Age range
- from 18 Years to 90 Years
- Healthy volunteers
- true
- Results posted
- No results posted in this snapshot
- Countries
- United States
- Total sites listed
- 1
Eligibility criteria
Show eligibility criteria (verbatim from the registry)
Inclusion criteria: * Patients with pain \>3 months who are using oral analgesic including narcotics and or physical therapy to reduce pain. * Patient provides informed consent * Older than 21 years old, * Previously have used CBD or marijuana * Speaks English Exclusion criteria: * Patients who are receiving interventional pain procedures or surgery within 30 days * for their pain * Patients who have had pain \<3 months * Presence of serious medical illness * Pregnant females * Use of P450 modifying medications.
Source: ClinicalTrials.gov (US National Library of Medicine), snapshot October 2026. Check the registry for current recruiting status. Record: https://clinicaltrials.gov/study/NCT04729244